FORT MYERS, FL., Dec. 19, 2024 — American Oncology Network (AON) (OTCQX: AONC), one of the fastest-growing oncology networks in the United States, proudly announces that its specialty pharmacy has achieved reaccreditation from the Accreditation Commission for Health Care (ACHC).
Accreditation is a process through which health care organizations demonstrate compliance with national standards. ACHC accreditation reflects an organization’s dedication to meeting standards that facilitate a higher level of performance and patient care.
ACHC, a nonprofit organization, has been a symbol of quality and excellence since 1986. It is ISO 9001:2015 certified and has Centers for Medicare & Medicaid Services (CMS) deeming authority for home health, hospice, and durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS).
AON’s centralized, state-of-the-art specialty pharmacy partners with physicians and pharmacists to achieve optimal clinical outcomes by providing patients with convenient home delivery of quality, safe, and effective oral cancer medications. The AON pharmacy team ensures oral oncolytics are dispensed quickly and shipped directly to patients’ homes, while skilled insurance claim coordinators manage claims and connect patients to financial assistance programs.
“We are thrilled to receive reaccreditation from the Accreditation Commission for Health Care (ACHC),” said Doug Braun, AON’s vice president of pharmacy. “This recognition reflects our unwavering commitment to providing the highest quality care and services to our patients. Achieving ACHC accreditation demonstrates that we meet the rigorous standards set for excellence, and we are proud to continue building trust with the communities we serve.”
###
About American Oncology Network American Oncology Network (AON) (OTCQX: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 250 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.
About ACHC ACHC, a leading accreditor for DMEPOS suppliers and providers, offers a comprehensive suite of accreditation and distinction options for organizations, including Home/Durable Medical Equipment (HME) services.
With over 35 years of experience, ACHC has a history of driving success with industry-leading programs. ACHC develops solutions for healthcare providers worldwide and remains committed to delivering a customized, collaborative accreditation experience.
Multi-disciplinary and coordinated cancer treatment often involves multiple cancer specialists providing care, often at different locations, notes David Cohn, MD, interim chief executive officer for the OSUCCC – James. Shared medical records enhance communication across providers, improving care efficiency.
“By working together, we can harness the subspecialty knowledge of the OSUCCC – James with the community experience and convenience of Zangmeister to expedite and expand access for patients, get the right diagnosis upfront and connect patients with the best specialist for their type of cancer,” said Cohn.
This care can then be managed jointly from a community-based location or from the OSUCCC – James.
“What is most important is getting oncology patients timely access to quality oncology care and clinical trials. We can do more of this, and provide outstanding and convenient care, by collaborating,” said Cohn.
Improving timely access to oncology care
This new partnership marks a new approach to connecting community oncology with the subspecialized expertise of the OSUCCC – James and represents another important step toward increasing access to cancer diagnostics and treatment.
Cohn noted that, as the only NCI-designated Comprehensive Cancer Center in central Ohio, the OSUCCC – James serves as a hub of a much larger wheel that provides high-quality oncology care to patients.
“While we cannot treat every patient affected by cancer in Ohio, we can strategically partner with community-based practices like Zangmeister and our James Cancer Network affiliate hospitals to provide high quality cancer care that’s close to home, along with providing access to a robust portfolio of clinical trials,” said Cohn.
The OSUCCC – James is home to one of nine NCI-funded phase I/II clinical trial centers in the United States. Because of this, patients have access to the latest science-backed therapies that are available only in a clinical trial setting. The hospital is also home to the Pelotonia Institute for Immuno-oncology, which includes clinical cell therapy programs like CAR T and TIL available at only a few certified hospital programs and central Ohio’s only proton therapy treatment center.
“We deeply value our longstanding relationships with community partners and referring physicians. These connections have been essential in delivering exceptional patient care over many years,” said Jeanna Knoble, MD, medical oncologist and Zangmeister Managing Partner.
“We believe that there is an opportunity to further strengthen our collaboration and explore new avenues that benefit all stakeholders, particularly our shared patients.”
Moving forward, this partnership will allow Zangmeister to direct access to highly specialized cancer therapies when a specific clinical need arises. These therapies may not be readily available in the community and include options such as CAR T-cell therapy, stem cell transplants, additional clinical trials, and the subspecialized expertise that is only available at a designated comprehensive cancer center like Ohio State.
“We are incredibly proud to partner with the OSUCCC – James,” said Steven Swart, executive vice president at AON, an alliance of physicians and seasoned healthcare leaders that includes Zangmeister. “This partnership will ensure that patients in central Ohio have access to a comprehensive range of cancer care services, aligning with our commitment to delivering innovative, evidence-based, and comprehensive cancer care. We’re excited to create a seamless, efficient experience for patients receiving care at both Zangmeister and Ohio State.”
Community outreach collaboration, medical professional education opportunities
In addition to enhanced patient care coordination and access to subspecialty care, this partnership will put business parameters in place to allow the two institutions to collaborate on future community programs and partner in potential expansions of clinical services like surgery, radiation therapy and supportive care services that are currently available at the OSUCCC – James but not at Zangmeister.
The partnership will also provide Zangmeister physicians/providers and staff with opportunities for continuing medical education in subspeciality cancer topics. To learn more about cancer care and research at the OSUCCC – James, visit cancer.osu.edu or call 1-800-293-5066.
https://www.aoncology.com/wp-content/themes/aon-enfold-child/images/AON_Logo_White.svg00AON Website Managerhttps://www.aoncology.com/wp-content/themes/aon-enfold-child/images/AON_Logo_White.svgAON Website Manager2024-12-16 09:15:002024-12-14 16:23:09Ohio State to partner with Zangmeister Cancer Center to expand access to cancer care in central Ohio
Board-certified medical oncologist Katherine Exten, MD, joins the physician team.
COLUMBUS, OH., November 19, 2024 — Community oncology practice Zangmeister Cancer Center, a partner practice of American Oncology Network (AON) (OTCQX: AONC), is pleased to welcome Board-certified medical oncologist Katherine Exten, MD, to its physician care team. Dr. Exten is now accepting patients at the Columbus clinic.
Dr. Exten is Board-certified in hematology, medical oncology, and internal medicine. She earned her medical degree from the Ohio State University College of Medicine, completed her internship and residency in internal medicine at the Ohio State University Wexner Medical Center, and completed a fellowship in hematology and oncology at the University of Illinois at Chicago.
“I am excited to join the physician team at Zangmeister Cancer Center,” said Dr. Exten. “Zangmeister is known for providing innovative and exceptional patient-centered care – the kind that I pride myself on delivering – and I can’t wait to collaborate with the like-minded team.”
The Zangmeister team now includes 12 medical oncologists, two gynecologic oncologists, and eight advanced practice providers across three Ohio locations. The practice is committed to providing the community with innovative cancer care that is delivered holistically based on research and evidence-based medicine. Zangmeister cancer patients have access to a diverse range of services for diagnosis, treatment, clinical trials, survivorship, and patient support that are close to home, eliminating the need to travel long distances to receive care.
“We are excited to welcome Dr. Exten to Zangmeister Cancer Center,” said Zangmeister medical oncologist Dr. Jeanna Knoble. “She is extraordinarily knowledgeable and committed to delivering top-notch patient-first care, which will further enhance our ability to offer an exceptional patient experience here in Central Ohio. We are thrilled to have her join our Zangmeister team.”
“On behalf of AON, I am pleased to welcome Dr. Exten to Zangmeister Cancer Center, and the network,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “Dr. Exten’s background is impressive, and I am confident that our patients – and our team – will benefit immensely from her expertise and commitment to providing quality, patient-centered care in a community-based setting.”
For more information about AON, visit AONcology.com. For more information about Zangmeister Cancer Center visit zangcenter.com.
###
About American Oncology Network American Oncology Network (AON) (OTCQX: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 250 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.
About Zangmeister Cancer Center
Designed for easy access and patient comfort, the Zangmeister Cancer Center offers a holistic array of cancer care services, including diagnostic imaging and chemotherapy treatment, laboratory services, genetic consultation, a specialty pharmacy, social support services, and access to cancer clinical trials. Zangmeister’s highly skilled and compassionate physicians use the latest advancements in the diagnosis, treatment, and prevention of cancer and blood disorders. Learn more at zangcenter.com.
https://www.aoncology.com/wp-content/themes/aon-enfold-child/images/AON_Logo_White.svg00AON Website Managerhttps://www.aoncology.com/wp-content/themes/aon-enfold-child/images/AON_Logo_White.svgAON Website Manager2024-11-19 07:12:222024-12-10 07:19:25Zangmeister Cancer Center and American Oncology Network Welcome Dr. Katherine Exten
Local urologic practice opens new location to provide excellent urologic care to the Hot Springs Village community.
HOT SPRINGS VILLAGE, AR, Nov. 12, 2024 – Triple Crown Urology, a partner practice of American Oncology Network (AON) (OTCQX: AONC), has opened a new clinic in Hot Springs Village at 4419 North Highway 7, Suite 100. Current or prospective patients can call (501) 525-4555 for inquiries or to schedule an appointment with Laci Patton, MSN, APRN, FNP-C, who has begun seeing patients at this new location.
“We are excited to welcome patients to our new Hot Springs Village practice location, where we will provide the same high-quality care that we do in all of our clinics,” said Board-certified Triple Crown urologist, Nathan Littlejohn, MD. “We have a patient-first mindset, and we hold ourselves to a high standard of continuously providing exceptional, compassionate care, which is the standard in all of Triple Crown Urology’s 6 clinic locations. We look forward to serving our patients at our new clinic in Hot Springs Village.”
Triple Crown Urology has been delivering care to patients living in Hot Springs, Arkadelphia, Benton, Camden, Mena, and surrounding areas for many years. The practice ensures patients receive personalized care and treatment plans that are designed exclusively for their unique needs. As a community-based practice, Triple Crown Urology provides affordable care in a comfortable environment while offering high-quality, state-of-the-art treatment in convenient locations.
The practice is a partner of American Oncology Network, one of the nation’s fastest-growing community-based oncology networks. Through this partnership, Triple Crown Urology makes additional patient care and services available such as access to the in-house specialty pharmacy with home delivery of certain medications among other benefits.
“We are looking forward to welcoming our patients to the new space, where we will continue to prioritize their health and well-being,” said Dr. Littlejohn. “This new location will allow us to expand patient services and therapeutics, while also providing a large space for staff to deliver one-on-one care.”
About American Oncology Network American Oncology Network (AON) (OTCQX: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 250 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.
About Triple Crown Urology Triple Crown Urology is dedicated to providing excellent urologic care throughout Central and Southwest Arkansas. The practice specializes in diseases and complications of the male and female urinary system, which includes the kidneys, ureters, bladder, urethra, prostate, and male reproductive organs. Triple Crown Urology providers treat both benign and oncologic urologic issues using the latest advanced technology, and have expertise in minimally invasive surgery, including robotic surgery, endoscopy, laparoscopy, Aquablation, and more. With a focus on delivering personalized, patient-centered care through shared decision making, Triple Crown Urology is committed to providing the best possible patient experience throughout the healthcare journey. Learn more at triplecrownurology.com.
Local oncology practice moves to a new location to continue providing enhanced cancer care to the Hot Springs Village community.
HOT SPRINGS VILLAGE, AR, Nov. 6, 2024 – Genesis Cancer and Blood Institute, a partner practice of American Oncology Network (AON) (OTCQX: AONC), has relocated its clinic in Hot Springs Village to 4419 North Highway 7, Suite 100. Current or prospective patients can call (501) 623-2731 for inquiries or to schedule an appointment.
Board-certified medical oncologist and hematologist, Lingyi Chen, MD is the primary physician at Genesis Cancer and Blood Institute’s Hot Springs Village clinic, and she is joined by the practice’s experienced clinical team. The expanded clinic includes additional private exam rooms that provide dedicated space for patient-physician conversations, and an onsite pharmacy.
“Our Hot Springs Village practice location has moved, but our standards of patient care have not changed,” said Dr. Chen. “We hold ourselves to a high standard of continuously providing exceptional, compassionate care that is central to our patient-first mindset, and is the standard in all of Genesis Cancer and Blood Institute’s 11 clinic locations. We appreciate our patients’ continued trust and look forward to serving them at our new address in Hot Springs Village.”
Genesis Cancer and Blood Institute has been delivering care to patients living in Hot Springs Village, Hot Springs, Arkadelphia, Benton, Camden, Little Rock, Mena, Nashville, Russellville, and surrounding areas for many years. The practice ensures patients receive personalized care and treatment plans that are designed exclusively for their unique needs. As a community-based practice, Genesis Cancer and Blood Institute provides affordable care in a comfortable environment while offering high-quality, state-of-the-art treatment in convenient locations.
The practice is a partner of American Oncology Network, one of the nation’s fastest-growing community-based oncology networks. Through this partnership, Genesis Cancer and Blood Institute makes additional patient care and services available such as access to the in-house specialty pharmacy with home delivery of certain medications among other benefits.
“We are excited to welcome our patients to the new space, where we will continue to prioritize their health and well-being,” said Dr. Chen. “The relocation will allow us to expand patient services and therapeutics, while also providing a larger space for additional staff to deliver one-on-one care.”
For more information about AON, visit AONcology.com. For more information about Genesis Cancer and Blood Institute, visit genesiscancerblood.com.
###
About American Oncology Network American Oncology Network (AON) (OTCQX: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 250 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.
About Genesis Cancer and Blood Institute Specializing in the diagnosis and treatment of cancer and hematology, Genesis Cancer and Blood Institute is recognized for providing expert cancer care in Arkansas. The highly trained physicians, clinicians and staff are committed to ensuring the best possible outcomes for their patients. The medical oncology/hematology physicians at Genesis Cancer and Blood Institute include Dr. R. Timothy Webb, Dr. Robert T. Muldoon, Dr. Stephen “Fred” Divers, Dr. A. Lynn Cleveland, Dr. Lingyi Chen, Dr. Sunil Kakadia, Dr. Kristen Sager, Dr. Jim Chen, and Dr. Brad Baltz. Learn more at genesiscancerblood.com.
https://www.aoncology.com/wp-content/themes/aon-enfold-child/images/AON_Logo_White.svg00AON Website Managerhttps://www.aoncology.com/wp-content/themes/aon-enfold-child/images/AON_Logo_White.svgAON Website Manager2024-11-06 05:46:282024-11-06 05:48:34Genesis Cancer and Blood Institute Relocates Hot Springs Village Clinic to Larger Location
Medical professionals can explore open positions such as nurse practitioner, registered nurse, pharmacy technologist, and more
ASHEVILLE, N.C., Oct. 31, 2024 – Messino Cancer Centers (MCC), a community-based oncology practice and partner practice of American Oncology Network (AON) (OTCQX: AONC), is hosting a virtual hiring event for medical professionals to learn about open roles such as nurse practitioner, registered nurse, pharmacy technologist, and more, from 5:30 p.m. to 7:00 p.m.EST on Nov. 6, 2024.
Virtual attendees will have the opportunity to:
Explore Career Opportunities: Discover a variety of roles across different departments.
Meet Messino Cancer Centers’ Leadership Team: Engage with the leadership team and learn about Messino Cancer Centers’ mission and vision.
Learn How Messino Cancer Centers’ Medical Professionals Impact Patients: Understand how Messino Cancer Centers’ medical professionals contribute to groundbreaking cancer care and research.
Medical professionals who are passionate about making a difference in the fight against cancer and want to be part of a dedicated team that is transforming cancer care and research are encouraged to attend Messino Cancer Centers’Virtual Hiring Event:
Messino Cancer Centers is committed to advancing cancer treatment and improving patient outcomes while offering a supportive environment, ongoing professional development, and the chance to work on meaningful projects that make a real difference.
Messino Cancer Centers career opportunities can be viewed here.
About American Oncology Network American Oncology Network (AON) (OTCQX: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 250 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.
About Messino Cancer Centers Messino Cancer Centers provides treatment for adult patients diagnosed with all types of cancer and blood disorders. Messino Cancer Centers is grounded in the Western North Carolina region and devoted to providing personalized care of the highest quality to patients in community settings, close to where they live and work and where their loved ones are close by. We are proud of our 30-year history of providing the highest quality cancer treatment that is based on research and focused on the whole person. Learn more at messinocancercenters.com or follow us on Facebook.
https://www.aoncology.com/wp-content/themes/aon-enfold-child/images/AON_Logo_White.svg00AON Website Managerhttps://www.aoncology.com/wp-content/themes/aon-enfold-child/images/AON_Logo_White.svgAON Website Manager2024-10-31 06:18:572024-10-31 06:38:13Messino Cancer Centers to Host Virtual Hiring Event for Medical Professionals on Nov. 6
American Oncology Network and Vantage Health Technologies Partner to Improve Cancer Patient Outcomes with AI-enabled Value-Based Care Platform
FORT MYERS, FL., October 29, 2024 —American Oncology Network (AON) (OTCQX: AONC), one of the fastest-growing oncology networks in the United States, has partnered with Vantage Health Technologies to enhance access to and delivery of exceptional cancer care. Vantage’s AI-enabled platform provides real-time health data for actionable insights and next-best-actions that can promote better patient experiences and outcomes, reduce provider burnout, and lower the cost of care. The platform also helps AON further enhance its Value-Based Care model in community oncology.
“We are pleased to collaborate with Vantage Health Technologies to further enhance our ability to provide exceptional, patient-first care in our community-based cancer clinics across the country,” said Alti Rahman, chief strategy and innovation officer of American Oncology Network. “Everyone benefits from Value-Based Care models powered by actionable data that offer providers a more holistic, real-time picture of their patients so they can meet them where they are and help them make better-informed decisions. Providers have the information they need to offer exceedingly personalized and effective care, patient experiences and outcomes are expected to improve, and the cost of care can be reduced for the entire ecosystem. This partnership will further our ability to provide an exceptionally high-quality experience for all.”
The first phase of the partnership will harness Vantage’s SocialHealth360 solution to enhance patient navigation and care coordination services, with an emphasis on addressing Social Determinants of Health (SDoH) for vulnerable patients. The World Health Organization cites research indicating that SDoH, such as housing, food security, transportation, and health literacy, significantly influence up to more than half of patient outcomes. Initial findings attributed to the use of SocialHealth360 found that it helped improve patient experience, treatment outcomes, and total cost of care among cancer patients. Additionally, health professionals using Vantage’s SocialHealth360 are expected to save up to five to eight hours per week on administrative tasks through workflow efficiencies, which decreases burnout and increases time they can spend helping patients. Subsequent phases of the partnership will focus on applying AI solutions to operationalize upstream and downstream Value-Based Care use-cases.
Vantage Health Technologies is part of BroadReach Group, a global healthcare social enterprise. “Healthcare globally faces shortages of providers, shrinking budgets and inadequate resources,” said Dr. John Sargent, co-founder of BroadReach Group. “We believe that technology can be a game changer for these healthcare challenges by automating and streamlining time-consuming processes, by assisting providers to manage patients more efficiently, and by empowering patients to more effectively self-manage aspects of their care. We have been proving this for the past decade in multiple countries across three continents. Our partnership with AON allows us to deploy this experience and expertise to community oncology to ensure better patient outcomes and experience, to reduce staff burnout and create pioneering approaches to value-based care.”
###
About Vantage Health Technologies Vantage Health Technologies, part of BroadReach Group, sees a world where access to good health enables people to flourish. BroadReach Group helps health organizations deliver better outcomes, improved resource efficiency, cost savings, enhanced organizational performance, and sustainable systems.
Vantage delivers innovative artificial intelligence (AI)-enabled solutions for healthcare organizations to get the most impact out of their resources and to transform how work gets done. Its solutions go beyond dashboards, empowering health professionals to make the best decisions and take the next-best-actions at the best time. Vantage believes that data alone cannot solve the world’s most complex health challenges; it also requires a deep understanding of the social, cultural, and economic context in which people live.
About American Oncology Network American Oncology Network (AON) (OTCQX: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 250 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.
Vantage Health Technologies / BroadReach Media Contact Shelley Diesel Vantage Health Technologies Shelley.Diesel@brhc.com +27-215-148-300
American Oncology Network Media Contact Karen Riley Sawyer American Oncology Network Karen.Sawyer@AONcology.com +1-541-221-1472
https://www.aoncology.com/wp-content/themes/aon-enfold-child/images/AON_Logo_White.svg00AON Website Managerhttps://www.aoncology.com/wp-content/themes/aon-enfold-child/images/AON_Logo_White.svgAON Website Manager2024-10-29 04:48:272024-10-29 04:49:15AON and Vantage Health Partner to Enhance Cancer Care with AI
Board-certified medical oncologists Magali Van den Bergh, MD, Venkata Parsa, MD, and Shivtaj Mann, DO join the Cape Coral physician team.
CAPE CORAL, FL., October 22, 2024 — Community oncology practice Florida Oncology and Hematology, a partner practice of American Oncology Network (AON) (OTCQX: AONC), is pleased to announce patients now have another additional choice for medical oncology services in Lee County due to its continued expansion in Florida with the opening of its new location in Cape Coral where Board-certified medical oncologists Magali Van den Bergh, MD, Venkata Parsa, MD, and Shivtaj Mann, DO are now accepting patients. The new Cape Coral clinic – located at 326 Del Prado Blvd, Suite 301 – offers Cape Coral-area patients further opportunity to choose a community oncology care practice that best suits their unique needs.
Florida Oncology and Hematology’s Cape Coral location is equipped to deliver the latest cancer care and therapies. As a partner practice of AON, Florida Oncology and Hematology offers an on-site infusion room, in-house lab and pathology services, access to an in-house specialty pharmacy for oral oncolytics, and support with care coordination and financial counseling, among other benefits.
“We are pleased to welcome Drs. Van den Bergh, Parsa, and Mann to Florida Oncology and Hematology and American Oncology Network,” said AON’s chief executive officer Todd Schonherz. “This new clinic, coupled with the addition of these three doctors who all have impressive backgrounds with years of experience providing quality, patient-centered care in Lee County communities, allows Cape Coral-area cancer patients the autonomy to tailor their care delivery as best suits their individual needs, which dovetails with AON’s core value of patient-centered care. We look forward to the expertise they bring to the AON team.”
Dr. Van den Bergh, who also practices at the new Florida Oncology and Hematology Fort Myers location, is the medical director at the Cape Coral practice, working alongside Dr. Parsa and Dr. Mann. Dr. Van den Bergh is triple Board-certified in internal medicine, oncology, and hematology. She earned her medical degree from American University of the Caribbean, completed an internship and residency in internal medicine at the University of Connecticut, and completed a fellowship in hematology-oncology at H. Lee Moffitt Cancer Center and Research Institute/University of South Florida where she was appointed chief fellow.
“I am excited to serve as medical director at Florida Oncology and Hematology’s Cape Coral location,” said Dr. Van den Bergh. “Florida Oncology and Hematology provides innovative and exceptional patient-centered care – the kind that I pride myself on delivering – so it was an easy decision to join in August when we opened the Fort Myers location where I am also seeing patients.”
Dr. Parsa is triple Board-certified in internal medicine, oncology, and hematology, and board eligible in palliative care. He earned his medical degree from the All India Institute of Medical Sciences, completed his residency in internal medicine at Michigan State University, and his fellowship in hematology and oncology at the Karmanos Cancer Center at Wayne State University.
“Joining Florida Oncology and Hematology is an opportunity to work with a team of innovative and exceptional patient-centered providers whose high standards align with my personal patient care goals,” said Dr. Parsa. “I am looking forward to collaborating with the talented physician team.”
Dr. Mann is triple Board-certified in internal medicine, oncology, and hematology. He earned his medical degree from Nova Southeastern University, completed his internal medicine residency at Lehigh Valley Health Network, and his fellowship in hematology and oncology at the University of Arizona, where he served as chief fellow.
“I am committed to ensuring cancer patients receive personalized, patient-centered care, and I believe a community-based approach is the best way to achieve that,” said Dr. Mann. “I am excited to join the physician team at Florida Oncology and Hematology because they are dedicated to providing the high standard of care that I pride myself in delivering each and every day.”
Florida Oncology and Hematology has opened four new practice locations since August 2024. The Florida Oncology and Hematology team now includes seven medical oncologists across five Florida locations, including the first Naples clinic that opened in August 2024, a Fort Myers clinic that opened in August 2024, and a second Naples clinic that opened in September 2024. The practice is committed to providing the communities it serves with innovative care for cancer and blood disorders that is delivered holistically based on research and evidence-based medicine. Florida Oncology and Hematology patients have access to a diverse range of services for diagnosis, treatment, clinical trials, survivorship, and patient support that are close to home, eliminating the need to travel long distances to receive care.
“On behalf of AON, I am thrilled to welcome Drs. Van den Bergh, Parsa, and Mann to Florida Oncology and Hematology and the network,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “All three of these doctors have impressive backgrounds, and I am confident that our patients – and our team – will benefit immensely from their expertise and commitment to providing quality, patient-centered care in a community-based setting.”
Drs. Van den Bergh, Parsa, and Mann began accepting new patients at the Florida Oncology and Hematology Cape Coral clinic on October 21, 2024.
For more information about AON, visit AONcology.com. For more information about Florida Oncology and Hematology, visit floridaonc.com.
###
About American Oncology Network American Oncology Network (AON) (OTCQX: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 250 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.
About Florida Oncology and Hematology
Specialists in the diagnosis and treatment of cancer and blood disorders, Florida Oncology and Hematology serves patients in Clearwater, Fort Myers, Naples, and Cape Coral, Florida. As a community-based practice, we offer a full range of exceptional cancer services, providing the highest quality treatment based on research and focused on the whole person. Learn more at floridaonc.com.
Local oncology practice expands its clinic moving to a larger suite in the same building to continue providing enhanced cancer care to the Conroe community.
CONROE, TX., Oct. 14, 2024 – Woodlands Cancer Institute, a partner practice of American Oncology Network (AON) (OTCQX: AONC), has expanded its clinic in Conroe and moved to a new, larger suite in the same building at 603 Conroe Medical Drive. The expanded clinic is now located at Suite 160. It is now open to new and current patients.
Board-certified medical oncologists, Eric P. Kleinbaum, MD, Sandeep “Kodi” Kodityal, MD, FACP, and Krishna K. Pachipala, MD, MRCP are the physicians at the newly expanded Woodlands Cancer Institute suite in Conroe, while Board-certified radiation oncologist Jason Berilgen, MD continues to see new and existing patients in the same building at 603 Conroe Medical Drive, in Suites 100 and 110. The newly expanded clinic in Suite 160 offers four private exam rooms that provide dedicated space for patient-physician conversations and 12 infusion chairs for patients receiving certain therapies as part of their treatment plans. The new suite is also equipped with an onsite laboratory for immediate blood draws and other necessary procedures.
“Our clinic has expanded to a new suite in the same conveniently located building to provide additional services to our patients,” said Dr. Kleinbaum. “We hold ourselves to a high standard of continuously providing exceptional care and services to our patients in a compassionate and holistic manner that is central to our patient-first mindset. This is the standard in all three Woodlands Cancer Institute clinic locations. We appreciate our patients’ continued trust and look forward to serving them at our newly expanded clinic in Conroe.”
Woodlands Cancer Institute has been delivering care to patients living in Conroe and the surrounding area for many years. The practice ensures patients receive personalized care and treatment plans that are designed exclusively for their unique needs. As a community-based practice, Woodlands Cancer Institute provides affordable care in a comfortable environment while offering high-quality, state-of-the-art treatment in convenient locations.
The practice is a partner of American Oncology Network, one of the nation’s fastest-growing community-based oncology networks. Through this partnership, Woodlands Cancer Institute makes additional patient care and services available such as access to the in-house specialty pharmacy with home delivery of certain medications among other benefits.
“We cannot wait to welcome our patients to the new space, where we will continue to prioritize their health and well-being,” said Dr. Kleinbaum. “The new suite will allow us to expand patient services and therapeutics, while also providing a larger space for additional staff to deliver one-on-one care.”
For more information about AON, visit AONcology.com. For more information about Woodlands Cancer Institute, visit woodlandscancer.com.
###
About American Oncology Network American Oncology Network (AON) (OTCQX: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 250 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.
About Woodlands Cancer Institute Woodlands Cancer Institute is a community-based medical oncology, radiation oncology and hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. Through compassionate care that centers around the patient, we strive to provide the best possible experience to patients and their families throughout the healthcare journey. Learn more at woodlandscancer.com.
https://www.aoncology.com/wp-content/themes/aon-enfold-child/images/AON_Logo_White.svg00AON Website Managerhttps://www.aoncology.com/wp-content/themes/aon-enfold-child/images/AON_Logo_White.svgAON Website Manager2024-10-14 08:08:102024-10-14 08:08:12New Clinic Suite, Same Personalized Care: Woodlands Cancer Institute Expands Its Conroe Location
Local oncology practice relocates to new location and adds additional clinic day to continue providing enhanced cancer care to the Mena community.
MENA, AR, Sept. 17, 2024 – Genesis Cancer and Blood Institute, a partner practice of American Oncology Network (AON) (OTCQX: AONC), has relocated its clinic in Mena to 400 Crestwood Circle Medical Office, Suite G. The clinic is expanding its services with staff available onsite from 8 a.m. to 4 p.m. Monday through Friday to better serve patients. Current or prospective patients can call (479) 385-8011 for inquiries or to schedule an appointment.
Board-certified medical oncologist and hematologist, Kristen Sager, MD is the primary physician at Genesis Cancer and Blood Institute’s Mena clinic, and she is joined by the practice’s experienced clinical team. The expanded clinic includes additional private exam rooms that provide dedicated space for patient-physician conversations, and additional lab testing capabilities.
“While our clinic has a new address, our standards of patient care have not changed,” said Dr. Sager. “The practice holds itself to a high standard of continuously providing exceptional care and services to our patients in a compassionate and holistic manner that is central to our patient-first mindset. This is the standard in all of Genesis Cancer and Blood Institute’s 12 clinic locations. We appreciate our patients’ continued trust and look forward to serving them at our new address in Mena.”
Genesis Cancer and Blood Institute has been delivering care to patients living in Mena, Arkadelphia, Benton, Camden, Hot Springs, Hot Springs Village, Little Rock, Malvern, Nashville, Russellville, and surrounding areas for many years. The practice ensures patients receive personalized care and treatment plans that are designed exclusively for their unique needs. As a community-based practice, Genesis Cancer and Blood Institute provides affordable care in a comfortable environment while offering high-quality, state-of-the-art treatment in convenient locations.
The practice is a partner of American Oncology Network, one of the nation’s fastest-growing community-based oncology networks. Through this partnership, Genesis Cancer and Blood Institute makes additional patient care and services available such as access to the in-house specialty pharmacy with home delivery of certain medications among other benefits.
“We cannot wait to welcome our patients to the new space, where we will continue to prioritize their health and well-being,” said Dr. Sager. “The relocation will allow us to expand patient services and therapeutics, while also providing a larger space for additional staff to deliver one-on-one care.”
For more information about AON, visit AONcology.com. For more information about Genesis Cancer and Blood Institute, visit genesiscancerblood.com.
###
About American Oncology Network American Oncology Network (AON) (OTCQX: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 250 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.
About Genesis Cancer and Blood Institute Specializing in the diagnosis and treatment of cancer and hematology, Genesis Cancer and Blood Institute is recognized for providing expert cancer care in Arkansas. The highly trained physicians, clinicians and staff are committed to ensuring the best possible outcomes for their patients. The medical oncology/hematology physicians at Genesis Cancer and Blood Institute include Dr. R. Timothy Webb, Dr. Robert T. Muldoon, Dr. Stephen “Fred” Divers, Dr. A. Lynn Cleveland, Dr. Lingyi Chen, Dr. Sunil Kakadia, Dr. Kristen Sager, Dr. Jim Chen, and Dr. Brad Baltz. Learn more at genesiscancerblood.com.
https://www.aoncology.com/wp-content/themes/aon-enfold-child/images/AON_Logo_White.svg00AON Website Managerhttps://www.aoncology.com/wp-content/themes/aon-enfold-child/images/AON_Logo_White.svgAON Website Manager2024-09-17 05:53:222024-09-17 05:56:29Genesis Cancer and Blood Institute Relocates Mena Clinic to Larger Location; Adds Clinic Day
